Statin prescribing in Australia: socioeconomic and sex differences - A cross-sectional study
Date
2004
Authors
Stocks, N.
Ryan, P.
McElroy, H.
Allan, J.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Medical Journal of Australia, 2004; 180(5):229-231
Statement of Responsibility
Nigel P Stocks, Philip Ryan, Heather McElroy and James Allan
Conference Name
Abstract
OBJECTIVE: To assess if there are any differences in statin prescribing across Australia by socioeconomic status or sex and to relate prescribing rates to coronary heart disease (CHD) mortality rates. DESIGN: Cross-sectional study using data on statin prescribing by age, sex and patient postcode for the period May to December 2002. SETTING AND PARTICIPANTS: The Australian population, stratified by sex and quintile of Index of Relative Socio-Economic Disadvantage (IRSD). MAIN OUTCOME MEASURES: Age-standardised rates of statin scripts per 1000 population per month for each sex and IRSD quintile. RESULTS: 9.1 million prescriptions for statins were supplied between May and December 2002, for a total cost of $570 million. The age-standardised rates for statin prescribing in women varied from 56.9 (95% CI, 56.6–57.2) scripts per 1000 population per month in the most disadvantaged socioeconomic quintile through 53.4 (95% CI, 53.0–53.7), 50.3 (95% CI, 50.0–50.6), 48.4 (95% CI, 48.1–48.7) to 46.3 (95% CI, 46.0–46.6) in the least disadvantaged quintile. For men the figures were 52.6 (95% CI, 52.3–52.9), 50.9 (95% CI, 50.6–51.2), 48.8 (95% CI, 48.6–49.1), 47.7 (95% CI, 47.4–47.9), and 51.9 (95% CI, 51.6–52.2). There was a significant linear association between statin prescribing and CHD mortality by quintile of socioeconomic disadvantage in women (weighted least squares slope, 0.380; 95% CI, 0.366 to 0.395; P < 0.0001), but not in men (slope, −0.002; 95% CI, −0.010 to 0.006; P = 0.65). Conclusions: Our results suggest that in men there is either overprescribing of statins in the highest socioeconomic quintile or underprescribing in the lowest. Furthermore, contrary to expectation, women — relative to men — are prescribed statins at higher rates at lower levels of risk (using CHD deaths as a proxy MJA 2004; 180: 229–231 measure of risk).
School/Discipline
Dissertation Note
Provenance
Description
The document attached has been archived with permission from the editor of the Medical Journal of Australia. An external link to the publisher’s copy is included.